Phibro Animal Health Corporation (PAHC) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $55.04 (+3.50%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 15, 2025 | Erin Wright | Morgan Stanley | $20.00 | -63.7% |
Top Analysts Covering PAHC
PAHC vs Sector & Market
| Metric | PAHC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | -11.0% | +1150.3% | +14.9% |
| P/E Ratio | 24.46 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $385M | $386M | $388M | 3 |
| 2026-09-30 | $404M | $407M | $410M | 1 |
| 2026-12-31 | $416M | $419M | $422M | 2 |
| 2027-03-31 | $428M | $431M | $434M | 1 |
| 2027-06-30 | $440M | $444M | $446M | 2 |
| 2028-06-30 | $1.60B | $1.60B | $1.60B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.68 | $0.72 | $0.78 | 3 |
| 2026-09-30 | $0.80 | $0.81 | $0.82 | 1 |
| 2026-12-31 | $0.92 | $0.93 | $0.94 | 1 |
| 2027-03-31 | $0.76 | $0.77 | $0.78 | 1 |
| 2027-06-30 | $0.68 | $0.69 | $0.70 | 1 |
| 2028-06-30 | $3.71 | $3.75 | $3.78 | 1 |
Frequently Asked Questions
What is the analyst consensus for PAHC?
The consensus among 1 analysts covering Phibro Animal Health Corporation (PAHC) is Buy with an average price target of $49.00.
What is the highest price target for PAHC?
The highest price target for PAHC is $20.00, set by Erin Wright at Morgan Stanley on 2025-04-15.
What is the lowest price target for PAHC?
The lowest price target for PAHC is $20.00, set by Erin Wright at Morgan Stanley on 2025-04-15.
How many analysts cover PAHC?
1 analysts have issued ratings for Phibro Animal Health Corporation in the past 12 months.
Is PAHC a buy or sell right now?
Based on 1 analyst ratings, PAHC has a consensus rating of Buy (2.00/5) with a -11.0% upside to the consensus target of $49.00.
What are the earnings estimates for PAHC?
Analysts estimate PAHC will report EPS of $0.72 for the period ending 2026-06-30, with revenue estimated at $386M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.